2021 annual financial data

Rein Therapeutics, Inc. 2021 Net margin

Rein Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -26,605 USD and net income was -26,164 USD.
Operating cash flow was -23,754,000 USD.

Get free Rein Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-26,605 USD
Net income
-26,164 USD
Operating cash flow
-23,754,000 USD